Posted on January 31st, 2012 by Health News
AMAG Pharmaceuticals, Inc. today announced the completion of patient enrollment in the second of the company’s two phase III studies that comprise its global registrational program for Feraheme (ferumoxytol) in patients with iron-deficiency anemia (IDA) who are not candidates for oral iron, regardless of the underlying cause.
No Comments »
Filed under: Pharmacy News
Posted on January 31st, 2012 by Health News
This unique and timely event will highlight how different frameworks and initiatives have succeeded in developing an efficient, environmentally friendly manufacturing process in the pharmaceutical industry…
No Comments »
Filed under: Pharmacy News
Posted on January 31st, 2012 by Health News
Baxter International Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved TISSEEL [Fibrin Sealant] to include general hemostasis in surgery when control of bleeding by standard surgical techniques is ineffective or impractical.
No Comments »
Filed under: Pharmacy News
Posted on January 31st, 2012 by Health News
Allos Therapeutics, Inc. today announced that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in January by the EMA’s Committee For Medicinal Products for Human Use (CHMP) for conditional approval of FOLOTYN (pralatrexate injection) for the treatment of patients with peripheral T-cell lymphoma (PTCL) [...]
No Comments »
Filed under: Pharmacy News
Posted on January 31st, 2012 by Health News
A drug used to treat multiple sclerosis may also be effective at preventing and reversing the leading cause of heart attack, a new study has found.
No Comments »
Filed under: Pharmacy News
Posted on January 31st, 2012 by Health News
Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg.
No Comments »
Filed under: Pharmacy News
Posted on January 31st, 2012 by Health News
Cell Therapeutics, Inc. announced today that it has voluntarily withdrawn its New Drug Application for Pixuvri (pixantrone) for the treatment of relapsed or refractory aggressive non-Hodgkin’s lymphoma in patients who failed two or more lines of prior therapy.
No Comments »
Filed under: Pharmacy News
Posted on January 31st, 2012 by Health News
The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.
No Comments »
Filed under: Pharmacy News
Posted on January 31st, 2012 by Health News
The Federal Trade Commission issued a complaint to block Omnicare, Inc.’s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. long-term care pharmacies would harm competition and enable Omnicare to raise the price of drugs for Medicare Part D consumers and others.
No Comments »
Filed under: Pharmacy News
Posted on January 30th, 2012 by Health News
Britons appear to be tightening their belts in more ways than one: 2011 audit figures from the British Association of Aesthetic Plastic Surgeons (BAAPS) revealed on Monday that the number of men undergoing tummy tucks (abdominoplasty) was 15% higher than in 2010…
No Comments »
Filed under: Men's Health
